Reno, Bo Italy ) and LPS (Sigma-Aldrich), or rhIL-4 (Pepro Tech). Moreover in selected experiments PMA-induced THP-1 cells were also pre-treated with the neutralizing humanized anti-HGF moAb L2G7 obtained under a Material Transfer Agreement with Galaxy Biotech (Cupertino, CA,USA).
Fluorescence microscopy and flow cytometry
Nurse-like cells (NLCs) were cultured in 8 well chambered cover glass. After 14 days B cells were vigourosly washed out while adherent cells were fixed with PBS+ 4% PFA and permeabilized with PBS+ 0,1% saponin. Cells were thus stained with primary antibodies anti-c-MET (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-IDO (Vinci-Biochem, Firenze, Italy), anti-vimentin (DakoCytomation,A/S; Glostrup, Denmark) or anti-CD68 (Biolegend Inc, San Diego, CA, USA) for 30 min and after two washes with a secondary moAb goat anti-rabbit alexa488-conjugated (Molecular Probes, Oregon USA) or a secondary goat anti-rabbit FITC or PE-conjugate or a goat anti-mouse-PE-conjugated (Jackson ImmunoResearch Laboratories, Baltimore, USA) moAb. To study IL-10 expression NLCs were preventively treated with monensin (Biolegend Inc, San Diego, CA, USA) for 4 hours. After this time cells were washed, fixed as described above and stained with a directly PE-conjugated anti-IL-10 antibody (Biolegend Inc). Fluorescein-conjugated anti-CD14,-CXCR4-(Immunotools) or the anti-CD163PE (Biolegend Inc) moAbs were also utilized to directly stain NLCs cultured in chamber slides or in 6-well plates. To analyze STAT3 activation NLCs derived in chamber slides were treated with HGF in sera-free medium for 40 min and further fixed, permeabilized and stained with a specific anti-pSTAT3 PE-conjugated moAb (Santa Cruz Biotechnology). Nuclear counterstainings were performed with DAPI (Invitrogen, Milan,Italy) Images were acquired on a Nikon Digital Sight DS-5Mc camera mounted on an Olympus BX51 fluorescence microscope, and recorded by the NIS-Element F software, release 2.20.
c-MET and IDO expression in NLCs or in fresh monocytes from PBMCs of CLL patients or from normal donors was also analyzed by flow cytometry (FacScan BD Biosciences, San Jose, CA, USA). In this case the cells were first detached by plates with trypsin, preventively fixed and permeabilized and further stained with primary unconjugated anti-c-MET or anti-IDO antibodies for 45 min at 4°C. After two washes permeabilized cells were stained with goat anti-rabbit alexa-488-conjugated or goat-anti-rabbit PE-or FITC-conjugated secondary antibodies. For analysis cells were gated on the basis of Forward Scatter (FSC)/Side Scatter (SSC) parameters and CD14 expression, and at least 3000 gated events were acquired. Only gated cells that were at least 95% CD14+ were analyzed for c-MET and IDO expression.
To quantify the pSTAT3 immunopositive cells area discriminating between HGF-treated oruntreated cells we performed image analysis using the National Institute of Health Image J freeware (release 1.38X; http://rsb.info.nih.gov/ij/). Photographs of untreated or HGF-stimulated cells, acquired under the same conditions, enlargement and resolution, were set to the identical color threshold; the boundaries of cell areas, in each image, were defined by a computerized procedure that automatically grouped contiguous tresholded pixels, immunopositive to PE-conjugated anti-p-STAT3 moAb, in the largest continuous close-curved outlines; the procedure tagged each outline and calculated its integrated density, i.e. the product of its area -in square pixels-and of its mean gray value -i.e. the average gray value of all pixels in the selection (for RGB images an automatic feature of the software allows conversion of colored pixels to relative gray values). The procedure provided a mirror image of all outlines in each photograph; only outlines that included DAPIpositive nuclei, upon superimposing the mirror image to its respective original one, were included in measurement calculations and subsequent analysis. Average values of integrated areas in HGFtreated cells were normalized to the values obtained in untreated cells from the same patient.
Analysis of STAT3 and pSTAT3 activation by Western Blot.
STAT3, pSTAT3 and Actin were also evaluated by Western Blotting in purified monocytes from normal donors, or from CLL patients or from NLCs at basal conditions or after HGF treatment as well as in THP1 cells as controls. NLCs and monocytes were cultured overnight in 24 well plates with RPMI+FCS2%. The day after the cells were treated with HGF (100ng/ml) for 40 min. Cells were thus gently scraped and total protein were extracted. THP1 cell line was utilized as positive control and also to choose the best time of treatment. Total proteins were extracted using the M-PER® Protein extraction reagent (Thermo Scientific, Pierce Biotechnology, Rockford, IL, USA).
Protein content was assessed by the Pierce BCA assay kit (Thermo Scientific). An equal amount of total protein lysates for each couple of sample (untreated and HGF treated) were subjected to 4%-12% SDS-PAGE separation and transferred on PVDF membranes by standard Western blotting.
Membranes were blocked for 2h in TBS-T buffer (20 mM Tris/HCl; 0.5 M NaCl; 0.1% Tween20) containing 5% dry milk powder, washed three times in TBS-T and incubated overnight at 4°C with anti-STAT3 (Cell Signaling Technologies Inc., Danvers, MA, USA), anti-P-STAT3 primary antibody (Santa Cruz Biotechnology Inc., Santa Cruz, Ca., USA) or anti-actina (cat. n. A2228, Sigma -Aldrich Milan, Italy) in 5% low fat milk in TBS-T buffer. Immunodetection was performed adding specific anti-rabbit or anti-mouse HPR-linked secondary for 1h at room temperature, 
Immunohistochemistry and immunofluorescence analysis of lymphonodal and bone marrow biopsies.
For in situ single-marker immunohistochemical analysis sections were deparaffinized with xylene and rehydrated to water through a graded alcohol series. Antigen retrieval was performed using 10 mmol citrate buffer (pH 9.0) at high temperature for 20 min. Endogenous peroxidase activity was quenched with 3% hydrogen peroxide. Sections were incubated with anti-human c-MET (Santa Cruz Biotechnology) or anti-human IDO (Vinci-Biochem) at room temperature for 1 hour. Staining was performed with the Novolink Max Polymer Detection System (Leica Microsystems) using DAB (3,3'-Diaminobenzidine) substrate chromogen (Leica Microsystems). Finally, sections were countestained with hematoxilyn.
For immunofluorescence analysis tissue sections were deparaffinized with xylene and rehydrated to water through a graded alcohol series. Following antigen retrieval, the samples were incubated, by sequential immunostaining, with primary antibodies anti-human c-MET (Santa Cruz Biotechnology), anti-human IDO (Vinci-Biochem), anti-human CD163 (Biolegend Inc.), antihuman vimentin, and anti-human CD68 (Novocastra, Newcastle Upon Tyne, UK). After Fc blocking, Alexa 488 and Alexa 568 Fluor-conjugated secondary Abs (Invitrogen) were used. Slides were evaluated using a Leica DM2000 microscope equipped with a Leica DFC320 digital camera. 
RNA isolation and quantitative Real time PCR

Determination of the inibition of T cell proliferation by monocytes or NLCs from CLL patients.
In order to determine potential suppression of T cell proliferation, peripheral blood mononuclear cells (PBMCs), separated from normal donors, were preventively labeled with carboxylfluoresceindiacetatesuccinimidyl-ester (CFSE) (Sigma). CFSE labeling will allow to quantify the number of cell division relative to T cell proliferation. Briefly PBMCs were resuspended in pre-warmed PBS One representative case of 5 studied.
Supplemental Figure 6
Representation of putative effects induced by HGF on surrounding cells of the microenvironment. 
